Evercare Hospital conducts Convalescent Plasma Therapy to combat Covid-19
The treatment holds lot of promise and the patient is being monitored
Evercare Hospital Dhaka conducted Convalescent Plasma Therapy for the first time in Bangladesh.
Successfully conducted in many developed countries recently, this Plasma Therapy is a promising research treatment to combat the global pandemic Covid-19, says a press release from the hospital.
"Covid-19 infected patients in serious condition require ICU and ventilators support. In addition to their regular treatment, research is being conducted worldwide to combat Covid-19, where one of the most promising treatments is Convalescent Plasma Therapy", said Dr. Abu Jafar Mohammed Saleh, Coordinator & Senior Consultant – Hematology & Stem Cell Transplant at Evercare Hospital Dhaka.
Keep updated, follow The Business Standard's Google news channel
He continued, "Plasma is taken from the blood of a formerly-infected, fully recovered Covid-19 patient that contain IGG (Immunoglobulin G) antibodies against the virus. We have collected plasma from one such donors and transfused it to a Covid-19 patient in the ICU who is under ventilator." Dr. Saleh said that in his opinion, the treatment holds lot of promise and the patient is being monitored.
Evercare Hospital Dhaka is committed to the wellbeing and health of their patients, and this is one such groundbreaking and exemplary initiative to help the people during this global crisis.
Evercare is an integrated healthcare delivery platform operating in growth markets across Africa and South Asia, including Bangladesh, India, Pakistan, Kenya and Nigeria. Evercare helps communities thrive by improving patient access to clinic and hospital operations, leveraging technology and integration to increase the quality of care. Evercare is building a foundation of continuous quality improvement and standardized care to improve clinical outcomes and patient safety. Evercare's portfolio includes 28 hospitals, 18 clinics, 54 diagnostic centers and two hospitals under construction. Evercare is wholly owned by the Evercare Health Funds, a US$ 1bn emerging markets healthcare fund managed by The Rise Funds, the impact investment platform of global alternative asset manager TPG. The Evercare Health Fund is comprised of the world's leading development finance institutions and other impact investors around the world.
